Liqi Li

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Breast Cancer Cells

Disease Activity

Artificial Intelligence

Rheumatoid Arthritis Patients

Top Venues

Arthritis & rheumatology (Hoboken, N.J.)

Diseases of the colon and rectum

Current molecular pharmacology

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Zheng, Jun He, Liqi Li
The dysbiosis of the gut microbiome in spondyloarthritis patients is correlated with both disease activity and HLA-B27 status. Arthritis & rheumatology (Hoboken, N.J.) 76 (7) (2024)
Liqi Li
Comment on: Artificial Intelligence-Based Total Mesorectal Excision Plane Navigation in Laparoscopic Colorectal Surgery. Diseases of the colon and rectum 67 (5) (2024)
Liqi Li
Letter: Effect of dietary additives on intestinal barrier and acute stress in healthy adults. Alimentary pharmacology & therapeutics (2024)
Liqi Li
Comment on: Artificial Intelligence-Based Total Mesorectal Excision Plane Navigation in Laparoscopic Colorectal Surgery. Diseases of the colon and rectum 67 (5) (2024)
Yi Zheng, Jun He, Liqi Li
Comment on: Both disease activity and HLA-B27 status are associated with gut microbiome dysbiosis in spondyloarthritis patients. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Yi Zheng, Jun He, Liqi Li
The dysbiosis of the gut microbiome in spondyloarthritis patients is correlated with both disease activity and HLA-B27 status. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Liqi Li, Yunyun Li, Xiaoshu Zhou
Advancements in the Research of GEF-H1: Biological Functions and Tumor Associations. Current molecular pharmacology 17 (2024)
Xuemei Yao, Wei Li, Liqi Li, Menghuan Li, Youbo Zhao, De Fang, Xiaohua Zeng, Zhong Luo
YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis. Cell death & disease 13 (3) (2022)